Article info
PDFCOVID-19
Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Correspondence to Professor Seung Won Lee, Sejong University College of Software Convergence, Seoul 05006, Korea; lsw2920{at}gmail.com; Professor In Kyung Yoo, CHA University School of Medicine, Seongnam 13497, Korea; lemonherb12{at}cha.ac.kr; Dr Dong Keon Yon, CHA University School of Medicine, Seongnam 13497, Korea; yonkkang{at}gmail.com
Citation
Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
Publication history
- Received June 16, 2020
- Revised July 9, 2020
- Accepted July 11, 2020
- First published July 30, 2020.
Online issue publication
April 15, 2021
Article Versions
- Previous version (15 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage